eplerenone:

Giacomo Boscia1, Pasquale Viggiano1, Federica Marzulli1

  • 1Department of Translational Biomedicine Neuroscience, University of Bari "Aldo Moro", Bari, Italy.

概括

在患有慢性中央血清性胆色素变异症 (cCSC) 的患者中,口服eplerenone (EPL) 治疗改善了视力,并减少了视网膜和冠状腺变化. 这些EPL的积极影响持续了长达四年.